94423 ⎘
Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms One oxygen atom
ACSS2 INHIBITORS AND METHODS OF USE THEREOF
#2DIARYLHYDANTOIN COMPOUNDS
#3TRYPTAMINE ANALOGUES
#4FORMATION OF AMIDINES AND INTRAMOLECULAR REACTION THEREOF
#5DIARYLHYDANTOIN COMPOUNDS
#6N-ACYL AMINO ACID COMPOUNDS AND METHODS OF USE
#7METHIONINE METABOLIC PATHWAY INHIBITORS
#8IMIDAZOLE 3-OXIDE DERIVATIVE BASED ACSS2 INHIBITORS AND METHODS OF USE THEREOF
#9DIARYLHYDANTOIN COMPOUNDS
#10ACSS2 INHIBITORS AND METHODS OF USE THEREOF
#11EP2 ANTAGONIST
#12METHOD FOR PRODUCING DIFLUOROMETHYL-SUBSTITUTED AROMATIC HETEROCYCLIC COMPOUND
#13KDM INHIBITORS AND USES THEREOF
#14EGFR dimer disruptors and use of the same
#15Thiol compound, method for synthesizing same, and uses for said thiol compound
#16MILD AND SITE-SELECTIVE 18F-LABELING OF SMALL MOLECULES AND/OR BIOMOLECULES VIA A THIOL-REACTIVE SYNTHON
#174-METHYLDIHYDROPYRIMIDINONE COMPOUNDS AND PHARMACEUTICAL USE THEREOF
#182-naphthimidamides, analogues thereof, and methods of treatment using same
#19DIARYLHYDANTOIN COMPOUNDS
#20INHIBITORS OF ALPHA-AMINO-BETA-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE
#21Proteasome inhibitors and uses thereof
#22Dyes for Analysis of Soluble Protein Aggregates or Misfolded Protein Oligomers
#23N-acyl amino acid compounds and methods of use
#24EGFR dimer disruptors and use of the same
#25Methionine metabolic pathway inhibitors
#26Hydantoins that modulate BACE-mediated app processing
#27DIARYLHYDANTOIN COMPOUNDS
#28HYDANTOINS THAT MODULATE BACE-MEDIATED APP PROCESSING
#294-methyldihydropyrimidinone compounds and pharmaceutical use thereof
#30DIARYLHYDANTOIN COMPOUNDS
#31Substituted imidazole derivatives and methods of use thereof
#32Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
#33Proteasome inhibitors and uses thereof
#34Hydantoins that modulate BACE-mediated APP processing
#35N-acyl amino acid compounds and methods of use
#36Diarylhydantoin Compounds
#37Neprilysin inhibitors
#38Herbicidal compounds
#39Water-soluble triazabutadienes
#40Neprilysin inhibitors
#41Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
#42Fluorination of organic compounds
#43Compounds
#44Hydantoins that modulate BACE-mediated APP processing
#45Aryl sulfide derivatives and aryl sulfoxide derivatives as acaricides and insecticides
#46Hydantoins that modulate bace-mediated app processing
#47Packaged product of solid preparation containing 5-hydroxy-1H-imidazole-4-carboxamide or salt thereof, or hydrate thereof
#48Glucagon receptor modulators
#49Process for extracting polyester from an article
#50Neprilysin inhibitors
#51Dual-acting imidazole antihypertensive agents
#523-O-heteroaryl-ingenol
#53Crystalline forms of an alkoxyimidazol-1-ylmethyl biphenyl carboxylic acid
#54Heterocyclic aspartyl protease inhibitors
#55Dual-acting antihypertensive agents
#56Modulators for Sirt5 and assays for screening same
#57Packaged product of solid preparation containing 5-hydroxy-1H-imidazole-4-carboxamide or salt thereof, or hydrate thereof
#58Process for preparing biphenyl imidazole compounds
#59Glucagon receptor modulators
#60Neprilysin inhibitors
#61Dual-acting imidazole antihypertensive agents
#62Azole derivative
#63Compositions for Topical Application Having Androgenic Actions
#64Imidazole compounds that modulate HSP90 activity
#65Heterocyclic aspartyl protease inhibitors
#66Intermediates for preparing dual-acting benzyl triazole antihypertensive agents having angiotensin II type I receptor antagonist activity and neprilysin-inhibition activity
#67Process for preparing biphenyl imidazole compounds
#68Glucagon receptor modulators
#69Neprilysin inhibitors
#70Imidazolone-chalcone derivatives as potential anticancer agent and process for the preparation thereof
#71Compounds, Compositions and Methods of Using Same for Modulating Uric Acid Levels
#72DIARYLHYDANTOIN COMPOUNDS
#73Heterocyclic aspartyl protease inhibitors
#74NOVEL SPIRO IMIDAZOLONES AS GLUCAGON RECEPTOR ANTAGONISTS, COMPOSITIONS, AND METHODS FOR THEIR USE
#75SUBSTITUTED ARYLIMIDAZOLONE AND TRIAZOLONE AS INHIBITORS OF VASOPRESSIN RECEPTORS
#76Crystalline form of an alkoxyimidazol-1-ylmethyl biphenyl carboxylic acid
#77Treatment of hyperproliferative disorders with diarylhydantoin compounds
#78CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS
#79Compositions For Topical Application Having Androgenic Actions
#80Dual-acting antihypertensive agents
#81Dual-acting antihypertensive agents
#82Substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof
#83Neprilysin inhibitors
#84Process for preparing biphenyl imidazole compounds
#85Glucagon receptor modulators
#86Dual-acting imidazole antihypertensive agents
#87Crystalline forms of an alkoxyimidazol-1-ylmethyl biphenyl carboxylic acid
#88Method for producing vinyl ether
#89Dual-acting antihypertensive agents
#90Dual-acting antihypertensive agents
#91Crystalline form of an alkoxyimidazol-1-ylmethyl biphenyl carboxylic acid
#92Crystalline alkoxyimidazol-1-ylmethyl biphenyl carboxylic acid and methods for preparing thereof
#93Heterocyclic aspartyl protease inhibitors
#945-ring heteroaromatic compounds and their use as binding partners for 5-HT5 receptors
#95Compounds as antagonists or inverse agonists at opioid receptors
#96Substituted imidazole derivatives and methods of use thereof
#97COMPOUNDS AND METHODS FOR THIOL-CONTAINING COMPOUND EFFLUX AND CANCER TREATMENT
#98Dual-acting imidazole antihypertensive agents
#99Process for preparing biphenyl imidazole compounds
#100Compositions for Topical Application Having Androgenic Actions
#101ACETYL MIMIC COMPOUNDS FOR THE INHIBITION OF ISOPRENYL-S-CYSTEINYL METHYLTRANSFERASE
#102Substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof
#103DIARYLHYDANTOIN COMPOUNDS
#104UROCANIC ACID DERIVATIVES USEFUL FOR THE TREATMENT OF IMMUNE-RELATED AND INFLAMMATORY DISEASES
#105Treatment of hyperproliferative disorders with diarylhydantoin compounds
#106Amino-5-[4-(difluoromethoxy)phenyl]-5-phenylimidazolone Compounds For The Inhibition Of Beta-secretase
#107Crystalline form of an alkoxyimidazol-1-ylmethyl biphenyl carboxylic acid
#108Certain Chemical Entities, Compositions, and Methods
#109Compounds, compositions and methods of using same for modulating uric acid levels
#110Compounds, compositions and methods of using same for modulating uric acid levels
#111SUBSTITUTED TRIAZOLINE, TETRAZOLONE AND IMIDAZOLONE DERIVATIVES FOR USE AS A MEDICINE
#112Substituted arylimidazolone and triazolone as inhibitors of vasopressin receptors
#113Imidazopyridinyl benzamide mitotic kinesin inhibitors
#114Imidazopyridinyl benzamide mitotic kinesin inhibitors
#115Heterocyclic aspartyl protease inhibitors
#116CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS
#117Dual-acting antihypertensive agents
#118Substituted amides
#119Heterocyclic aspartyl protease inhibitors
#120Binding inhibitor of sphingosine-1-phosphate
#121Scalable synthesis of imidazole derivatives
#122Organic compounds
#123Compositions for topical application having androgenic actions
#124Amino-5-[4-(difluoromethoxy)phenyl]-5-phenylimidazolone compounds for the inhibition of beta-secretase
#125Dual-acting imidazole antihypertensive agents
#1264-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazole-2-ones and, 4-(substituted cycloalkylmethyl) imidazole-2-ones and related compounds
#127Therapeutic Agents
#128Dual-acting antihypertensive agents
#129Certain chemical entities, compositions, and methods
#130COMPOUNDS TO TREAT AMYLOIDOSIS AND PREVENT DEATH OF BETA-CELLS IN TYPE 2 DIABETES MELLITUS
#1314-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cycloalkenylmethyl) imidazole-2-ones and related compounds
#132Phenylazo-acetoacetanilide derivatives with a polymerizable functional group and related compounds as monomers for preparing polymeric pigment dispersants for inkjet inks
#133Substituted pyridyoxy amides
#1342-((2-thioxo-2,3-dihydro-1H-imidazol-4-yl)methyl)-3,4-dihydronaphthalen-1(2H)-one
#135Imidazole-2-thiones
#136Imidazole-2-thiones
#1374-(2-methyl-5,6,7,8-tetrahydro-quinolin-7-ylmethyl)-1,3-dihydro-imidazole-2-thione as specific alphaagonist and methods of using the same
#138Compounds, Compositions, and Methods
#139Compositions useful as inhibitors of voltage-gated sodium channels
#140Method of making imidazole-2-ones and 2-thiones
#141Imidazoyl-benzamide anti-cancer agents
#142Cardiotonic compounds with inhibitory activity against beta-adrenergic receptors and phosphodiesterase
#143Heat- or singlet oxygen-generating agents and cancer treatment compositions comprising organic peroxide or chemiluminescent compound
#144Imidazole compounds that modulate HSP90 activity
#1454-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cycloalkenylmethyl) imidazol-2-ones and related compounds
#146Heterocyclic aspartyl protease inhibitors
#147Compounds with mixed pde-inhibitory and beta-adrenergic antagonist or partial agonist activity for treatment of heart failure
#148Diarylhydantoin compounds
#149Coating solution composition of photo-alignment material
#150Compounds to treat amyloidosis and prevent death of beta-cells in type 2 diabetes mellitus
#151Substituted benzylimidazoles useful for the treatment of inflammatory diseases
#152N-(4-(imidazo[1,2A]pyridin-YL)phenethyl)benzamide inhibitors of the mitotic kinesin CENP-E for treating certain cellular proliferation diseases
#153Insecticidal phthalamide derivatives
#1544-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2- thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cyloalkenylmethyl) imidazol-2-ones and related compounds
#1552-((2-Thioxo-2,3-dihydro-1H-imidazol-4-yl)methyl)-3,4-dihydronapthalen-1(2H)-one
#156Compounds and methods for thiol-containing compound efflux and cancer treatment
#157Heterocyclic aspartyl protease inhibitors
#158Piperazine derivative
#159Enoximone sulfoxide enantiomers and their use in the treatment of PDE-III mediated diseases
#160Enoximone sulfoxide enantiomers and their use in the treatment of PDE-III mediated diseases
#1614-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4- (substituted cycloalkylmethyl) imidazol-2-ones and 4- (substituted cycloalkenylmethyl) imidazol-2-ones and related compounds
#162Scalable synthesis of imidazole derivatives
#163Substituted amides
#164Compositions for topical application having androgenic actions
#165Cyclic urea derivatives with 5-ht2c receptor activity
#166Process for the preparation of benzylimidazole derivatives
#1674-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones, 4-(substituted cycloalkenylmethyl) imidazol-2-ones and related compounds
#168Peroxisome proliferator activated receptor agonists
#169Azole compounds, process for preparation of the same and use thereof
#170Small molecule modulators of IL-17